Review article · 2023

CAR T-cell therapy in autoimmune diseases

Georg Andreas Schett, Andréas Mackensen, Dimitrios Mougiakakos

The Lancet, 402(10416), 2034–2044 · Published 22 September 2023 · DOI 10.1016/s0140-6736(23)01126-1

View at the publisherCite this paper

In brief

“CAR T-cell therapy in autoimmune diseases” is a 2023 review article by Georg Andreas Schett and 2 co-authors, published in The Lancet. OpenAlex counts 488 citations as of 19 November 2026, which puts it in the top 2% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
488
Most cited in
2026 (183)
Field-weighted impact
14.98
References
92
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Schett, G. A., Mackensen, A., & Mougiakakos, D. (2023). CAR T-cell therapy in autoimmune diseases. The Lancet, 402(10416), 2034–2044. https://doi.org/10.1016/s0140-6736(23)01126-1

MLA 9

Schett, Georg Andreas, et al. “CAR T-cell therapy in autoimmune diseases.” The Lancet, vol. 402, no. 10416, 2023, pp. 2034–2044. https://doi.org/10.1016/s0140-6736(23)01126-1.

Chicago

Schett, Georg Andreas, Andréas Mackensen, and Dimitrios Mougiakakos. 2023. “CAR T-cell therapy in autoimmune diseases.” The Lancet 402 (10416): 2034–2044. https://doi.org/10.1016/s0140-6736(23)01126-1.

Harvard

Schett, G. A., Mackensen, A. and Mougiakakos, D. (2023) ‘CAR T-cell therapy in autoimmune diseases’, The Lancet, 402(10416), pp. 2034–2044. doi:10.1016/s0140-6736(23)01126-1.

IEEE

G. A. Schett, A. Mackensen, and D. Mougiakakos, “CAR T-cell therapy in autoimmune diseases,” The Lancet, vol. 402, no. 10416, pp. 2034–2044, 2023, doi: 10.1016/s0140-6736(23)01126-1.

BibTeX

@article{schett2023cell,
  title     = {{CAR T-cell therapy in autoimmune diseases}},
  author    = {Schett, Georg Andreas and Mackensen, Andréas and Mougiakakos, Dimitrios},
  journal   = {The Lancet},
  year      = {2023},
  volume    = {402},
  number    = {10416},
  pages     = {2034--2044},
  doi       = {10.1016/s0140-6736(23)01126-1},
  url       = {https://doi.org/10.1016/s0140-6736(23)01126-1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202388
2024122122
2025175175
2026183183

Its field-weighted citation impact is 14.98: it has been cited 14.98 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • CAR T-cell therapy
  • autoimmune disease
  • autoreactive B cells
  • CD19
  • systemic lupus erythematosus
  • dermatomyositis
  • rheumatoid arthritis
  • multiple sclerosis

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Schett, G. A., Mackensen, A., & Mougiakakos, D. (2023). CAR T-cell therapy in autoimmune diseases. The Lancet, 402(10416), 2034–2044. https://doi.org/10.1016/s0140-6736(23)01126-1

How many times has this paper been cited?

488 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Georg Andreas Schett, Andréas Mackensen, Dimitrios Mougiakakos.

What is the DOI of this paper?

10.1016/s0140-6736(23)01126-1, permanently at https://doi.org/10.1016/s0140-6736(23)01126-1. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.